Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Nexturn Bio Inc. decided to invest in the development of a new drug pipeline for diabetes treatment using miRNA

prnasiaMay 07, 2021

Tag: Nexturn , RosVivo , miRNA , RSVI-301

PharmaSources Customer Service